Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1037389 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,501,616
+$1,957,664 QoQ
Shares Held
1,533,400
+56.6% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 103 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. BCYC ranks #71 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in BCYC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,501,616 1,533,400
2026-03-31 $4,543,952 979,300
2025-12-31 $4,011,528 566,600
2025-09-30 $4,014,738 518,700
2025-06-30 $2,212,880 318,400
2025-03-31 $2,559,735 301,500
2024-12-31 $3,773,000 269,500
2024-09-30 $6,168,938 272,600
2024-06-30 $6,614,432 326,800
2024-03-31 $4,125,930 165,700
2023-12-31 $1,907,440 105,500
2023-09-30 $1,647,380 82,000
2023-06-30 $1,809,368 70,900
2023-03-31 $1,316,613 61,900
2022-06-30 $2,570,696 153,200
2022-03-31 $2,825,828 64,399
2021-12-31 $4,454,405 73,179
2021-06-30 $443,256 14,600
2021-03-31 $800,516 26,800
2020-12-31 $1,457,540 81,200
2020-09-30 $1,133,475 59,500
2020-06-30 $1,175,778 74,700
2020-03-31 $256,620 18,800